Immune Effector Cell Therapies for Immune Thrombocytopenia Concurrent With Hematologic Malignancy

Saarang R. Deshpande, Debbie Jiang, Rebecca K. Leaf, Andrew Song, P. Connor Johnson, Caron Jacobson, Jeremy Abramson, Hanny Al‐Samkari

Open source

DOI
10.1002/ajh.70505
Published
2026-09-23
Container
American Journal of Hematology
Publisher
Wiley
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/ajh.70505,
  title = {Immune Effector Cell Therapies for Immune Thrombocytopenia Concurrent With Hematologic Malignancy},
  author = {Saarang R. Deshpande and Debbie Jiang and Rebecca K. Leaf and Andrew Song and P. Connor Johnson and Caron Jacobson and Jeremy Abramson and Hanny Al‐Samkari},
  year = {2026},
  journal = {American Journal of Hematology},
  doi = {10.1002/ajh.70505},
  url = {https://doi.org/10.1002/ajh.70505}
}

RIS

TY  - JOUR
TI  - Immune Effector Cell Therapies for Immune Thrombocytopenia Concurrent With Hematologic Malignancy
AU  - Saarang R. Deshpande
AU  - Debbie Jiang
AU  - Rebecca K. Leaf
AU  - Andrew Song
AU  - P. Connor Johnson
AU  - Caron Jacobson
AU  - Jeremy Abramson
AU  - Hanny Al‐Samkari
PY  - 2026
JO  - American Journal of Hematology
DO  - 10.1002/ajh.70505
UR  - https://doi.org/10.1002/ajh.70505
ER  - 

APA

Deshpande, S. R., Jiang, D., Leaf, R. K., Song, A., Johnson, P. C., Jacobson, C., Abramson, J., & Al‐Samkari, H. (2026). Immune Effector Cell Therapies for Immune Thrombocytopenia Concurrent With Hematologic Malignancy. American Journal of Hematology. https://doi.org/10.1002/ajh.70505

Source records